Lung cancer is the second most frequently diagnosed cancer worldwide and a leading
cause of cancer-related deaths. Non-small cell lung carcinoma (NSCLC) represents 85% of …

miRNAs are some of the most well-characterized regulators of gene expression. Integral to
several physiological processes, their aberrant expression often drives the pathogenesis of …

Lung adenocarcinoma (LUAD) is a highly prevalent malignancy worldwide, and its clinical
prognosis assessment and treatment is a major research direction. Both ferroptosis and …

Background For early screening and diagnosis of non-small cell lung cancer (NSCLC), a
robust model based on plasma proteomics and metabolomics is required for accurate and …

For several decades, most lung cancer investigations have focused on the search for
mutations in candidate genes; however, in the last decade, due to the fact that most of the …

Despite enormous evolution in oncopharmacology, the non-small cell lung carcinoma
(NSCLC) is still among the most aggressive and prevalent types of cancer. Late diagnosis …

Lung cancer is the most common cause of cancer-related deaths in the world. One of the
reasons of poor prognosis and high mortality of lung cancer patients is the diagnosis of the …

Neuroendocrine neoplasms (NENs) comprise a highly heterogeneous group of tumors
arising from the diffuse neuroendocrine system. NENs mainly originate in gastrointestinal …

Lung cancer (LC) is the leading cause of cancer‑related death, with high incidence and
mortality rate. Early diagnosis and treatment of LC are imperative to improve the 5‑year …

Abstract The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas
technology is a molecular tool specific to sequences for engineering genomes. Among …